切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - RET - PARP - 15-PGDH - Voltage-gated Potassium (KV) Channels

17件产品中的 1-10

页面
每页
清除全部
  1. SW033291
    A8709 SW033291
    Target: 15-PGDH
    Summary: 15-PGDH酶抑制剂
      ≥20.65 mg/mL
      insoluble in H2O
  2. Rucaparib (free base)
    A8893 Rucaparib (free base)
    中文名: 瑞卡帕布
    Target: PARP
    Summary: PARP抑制剂
      ≥16.15 mg/mL
      insoluble in H2O
  3. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  4. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  5. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  6. ME0328
    A8808 ME0328
    Target: PARP
    Summary: PARP抑制剂
      ≥71.43 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  9. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  10. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    中文名: 维利帕尼二盐酸盐
    Target: PARP
    Summary: PARP-1/PARP-2抑制剂
      ≥31.7 mg/mL
      ≥104 mg/mL

17件产品中的 1-10

页面
每页